Hetlioz LQ

Trials studying Hetlioz LQ

• phase3Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)active not recruitingn=70
• EP1The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD)terminatedn=20
• phase3Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomniarecruitingn=420
• phase3Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variantrecruitingn=60
• phase3Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perceptionactive not recruitingn=140
• phase1Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescentscompletedn=24
• phase1Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjectscompletedn=48
• phase3Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbancesunknownn=100